Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer
Status:
Completed
Trial end date:
2019-10-28
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well combination chemotherapy works in treating patients with
advanced stomach, gastroesophageal, or esophageal cancer. Drugs used in chemotherapy, such as
irinotecan hydrochloride, oxaliplatin, leucovorin calcium, and fluorouracil, work in
different ways to stop the growth of tumor cells, either by killing the cells or by stopping
them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor
cells.